Advancing Non-Invasive Prenatal Screening: A Targeted 1069-Gene Panel for Comprehensive Detection of Monogenic Disorders and Copy Number Variations
Genes · 02.04.2025 · 16 (4) · 427
DOI: 10.3390/genes16040427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 02.04.2025. Verfasst von Roberto Sirica und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centro AMES, 80013 Casalnuovo di Napoli, Italy. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Noninvasive Prenatal Testing, Prenatal Diagnosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro AMES.
Abstract (Originalsprache)
We introduce an innovative, non-invasive prenatal screening approach for detecting fetal monogenic alterations and copy number variations (CNVs) from maternal blood.
Method
Circulating free DNA (cfDNA) was extracted from maternal peripheral blood and processed using the VeriSeq NIPT Solution (Illumina, San Diego, CA, USA), with shallow whole-genome sequencing (sWGS) performed on a NextSeq550Dx (Illumina). A customized gene panel and bioinformatics tool, named the “VERA Revolution”, were developed to detect variants and CNVs in cfDNA samples. Results were compared with genomic DNA (gDNA) extracted from fetal samples, including amniotic fluid and chorionic villus sampling and buccal swabs.
Results
The study included pregnant women with gestational ages from 10 + 3 to 15 + 2 weeks (mean: 12.1 weeks). The fetal fraction (FF), a crucial measure of cfDNA test reliability, ranged from 5% to 20%, ensuring adequate DNA amount for analysis. Among 36 families tested, 14 showed a wild-type genotype. Identified variants included two deletions (22q11.2, and 4p16.3), two duplications (16p13 and 5p15), and eighteen single-nucleotide variants (one in CFTR, three in GJB2, three in PAH, one in RIT1, one in DHCR7, one in TCOF1, one in ABCA4, one in MYBPC3, one in MCCC2, two in GBA1 and three in PTPN11). Significant concordance was found between our panel results and prenatal/postnatal genetic profiles.
Conclusions
The “VERA Revolution” test highlights advancements in prenatal genomic screening, offering potential improvements in prenatal care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro AMES, 80013 Casalnuovo di Napoli, Italy.
- Istituto Nazionale Tumori di Napoli, IRCCS Fondazione Pascale, Via M. Semmola, 80131 Naples, Italy.
- Department of Gynecology and Obstetrics, Universiteti Katolik Zoja e Këshillit të Mirë, Rr. Dritan Hoxha, 1057 Tirane, Albania.
ORCID-Profile: Alessandro Ottaiano, Nadia Petrillo, Eloisa Evangelista, Luigia De Falco, Giovanni Savarese
Förderung
- Centro AMES
Zitieren
APA
Sirica, R., Ottaiano, A., D'Amore, L., Ianniello, M., Petrillo, N., Ruggiero, R., Castiello, R., Mori, A., Evangelista, E., De Falco, L., Santorsola, M., Misasi, M., Savarese, G., & Fico, A. (2025). Advancing Non-Invasive Prenatal Screening: A Targeted 1069-Gene Panel for Comprehensive Detection of Monogenic Disorders and Copy Number Variations. Genes, 16(4), 427. https://doi.org/10.3390/genes16040427
Vancouver
Sirica R, Ottaiano A, D'Amore L, Ianniello M, Petrillo N, Ruggiero R, et al. Advancing Non-Invasive Prenatal Screening: A Targeted 1069-Gene Panel for Comprehensive Detection of Monogenic Disorders and Copy Number Variations. Genes. 2025;16(4):427. doi:10.3390/genes16040427
BibTeX
@article{Sirica2025,
author = {Sirica, Roberto and Ottaiano, Alessandro and D'Amore, Luigi and Ianniello, Monica and Petrillo, Nadia and Ruggiero, Raffaella and Castiello, Rosa and Mori, Alessio and Evangelista, Eloisa and De Falco, Luigia and Santorsola, Mariachiara and Misasi, Michele and Savarese, Giovanni and Fico, Antonio},
title = {Advancing Non-Invasive Prenatal Screening: A Targeted 1069-Gene Panel for Comprehensive Detection of Monogenic Disorders and Copy Number Variations},
journal = {Genes},
year = {2025},
volume = {16},
number = {4},
pages = {427},
doi = {10.3390/genes16040427}
}
EUVIMED